{"id":"https://openalex.org/W2120946253","doi":"https://doi.org/10.1200/jco.2006.07.0649","title":"Efficacy and Safety of Single-Agent Pertuzumab (rhuMAb 2C4), a Human Epidermal Growth Factor Receptor Dimerization Inhibitor, in Castration-Resistant Prostate Cancer After Progression From Taxane-Based Therapy","display_name":"Efficacy and Safety of Single-Agent Pertuzumab (rhuMAb 2C4), a Human Epidermal Growth Factor Receptor Dimerization Inhibitor, in Castration-Resistant Prostate Cancer After Progression From Taxane-Based Therapy","publication_year":2007,"publication_date":"2007-02-09","ids":{"openalex":"https://openalex.org/W2120946253","doi":"https://doi.org/10.1200/jco.2006.07.0649","mag":"2120946253","pmid":"https://pubmed.ncbi.nlm.nih.gov/17308272"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2006.07.0649","doi":"https://doi.org/10.1200/jco.2006.07.0649","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2006.07.0649","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.07.0649?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.07.0649?role=tab","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012095437","display_name":"David B. Agus","orcid":"https://orcid.org/0000-0002-7499-7822","observed_orcids":["https://orcid.org/0000-0002-7499-7822"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David B. Agus","raw_affiliation_strings":["From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002909668","display_name":"Christopher J. Sweeney","orcid":"https://orcid.org/0000-0002-0398-6018","observed_orcids":["https://orcid.org/0000-0002-0398-6018"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher J. Sweeney","raw_affiliation_strings":["From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017288060","display_name":"Michael J. Morris","orcid":"https://orcid.org/0000-0002-9454-0096","observed_orcids":["https://orcid.org/0000-0002-9454-0096"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Morris","raw_affiliation_strings":["From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075801763","display_name":"David S. Mendelson","orcid":"https://orcid.org/0000-0002-1555-8002","observed_orcids":["https://orcid.org/0000-0002-1555-8002"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David S. Mendelson","raw_affiliation_strings":["From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021686685","display_name":"Douglas G. McNeel","orcid":"https://orcid.org/0000-0003-1471-6723","observed_orcids":["https://orcid.org/0000-0003-1471-6723"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas G. McNeel","raw_affiliation_strings":["From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057559668","display_name":"Frederick R. Ahmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frederick R. Ahmann","raw_affiliation_strings":["From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100346128","display_name":"Jin Wang","orcid":"https://orcid.org/0000-0002-0062-2489","observed_orcids":["https://orcid.org/0000-0002-0062-2489"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jin Wang","raw_affiliation_strings":["From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049851359","display_name":"Mika Kakefuda Derynck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mika K. Derynck","raw_affiliation_strings":["From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077382664","display_name":"Kimmie Ng","orcid":"https://orcid.org/0000-0003-0631-1494","observed_orcids":["https://orcid.org/0000-0003-0631-1494"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimmie Ng","raw_affiliation_strings":["From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039801976","display_name":"Benjamin Lyons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Lyons","raw_affiliation_strings":["From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103421246","display_name":"David E. Allison","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David E. Allison","raw_affiliation_strings":["From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054374857","display_name":"Michael W. Kattan","orcid":"https://orcid.org/0000-0002-3840-4161","observed_orcids":["https://orcid.org/0000-0002-3840-4161"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael W. Kattan","raw_affiliation_strings":["From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072850546","display_name":"Howard I. Scher","orcid":"https://orcid.org/0000-0002-6791-9324","observed_orcids":["https://orcid.org/0000-0002-6791-9324"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard I. Scher","raw_affiliation_strings":["From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Cedars-Sinai Prostate Cancer Center, Los Angeles; Genentech Inc, South San Francisco, CA; Indiana University Medical Center, Indianapolis, IN; Memorial Sloan-Kettering Cancer Center, New York, NY; Premiere Oncology of Arizona, Scottsdale; Arizona Cancer Center, Tucson, AZ; University of Wisconsin, Madison, WI; and the Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":12.102,"has_fulltext":true,"cited_by_count":107,"citation_normalized_percentile":{"value":0.9886394,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"25","issue":"6","first_page":"675","last_page":"681"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":1.0},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.7620000243186951},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.5220000147819519},{"id":"https://openalex.org/keywords/survival-analysis","display_name":"survival analysis","score":0.6480000019073486},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8810464143753052},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.8366571664810181},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.7948088049888611},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6627945303916931},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5926942229270935},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5552842617034912},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5515558123588562},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5396803021430969},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5049880146980286},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.44919607043266296},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4154142737388611},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3439890146255493},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.18845683336257935},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.18367069959640503},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.10997045040130615},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009919","descriptor_name":"Orchiectomy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011336","descriptor_name":"Probability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016037","descriptor_name":"Single-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2006.07.0649","doi":"https://doi.org/10.1200/jco.2006.07.0649","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2006.07.0649","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.07.0649?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:17308272","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17308272","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":{"id":"doi:10.1200/jco.2006.07.0649","doi":"https://doi.org/10.1200/jco.2006.07.0649","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2006.07.0649","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.07.0649?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G9000877998","display_name":"Physician Scientist Training in Cancer Research","funder_award_id":"T32CA009172","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2120946253.pdf","grobid_xml":"https://content.openalex.org/works/W2120946253.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W1514463309","https://openalex.org/W1544742800","https://openalex.org/W1573265527","https://openalex.org/W1580523172","https://openalex.org/W1582187753","https://openalex.org/W1893360284","https://openalex.org/W1964321121","https://openalex.org/W1991647049","https://openalex.org/W2004542452","https://openalex.org/W2007558014","https://openalex.org/W2014457594","https://openalex.org/W2028743669","https://openalex.org/W2029409133","https://openalex.org/W2033488181","https://openalex.org/W2040829845","https://openalex.org/W2046183081","https://openalex.org/W2053838357","https://openalex.org/W2054082787","https://openalex.org/W2077863736","https://openalex.org/W2080439368","https://openalex.org/W2081991489","https://openalex.org/W2097017580","https://openalex.org/W2097256218","https://openalex.org/W2103526359","https://openalex.org/W2105829250","https://openalex.org/W2120292596","https://openalex.org/W2126841222","https://openalex.org/W2136160453","https://openalex.org/W2139248078","https://openalex.org/W2143618467","https://openalex.org/W2151425644","https://openalex.org/W2154077173","https://openalex.org/W2155679349","https://openalex.org/W2161987148","https://openalex.org/W2164592601","https://openalex.org/W2165003903","https://openalex.org/W2166609912","https://openalex.org/W2167869791","https://openalex.org/W2300122958","https://openalex.org/W2591173243","https://openalex.org/W2755747278","https://openalex.org/W4241518896"],"related_works":["https://openalex.org/W2243542663","https://openalex.org/W2012670037","https://openalex.org/W2106339174","https://openalex.org/W2591173243","https://openalex.org/W2106215754","https://openalex.org/W2790859009","https://openalex.org/W2096111541","https://openalex.org/W2520233921","https://openalex.org/W2746053356","https://openalex.org/W2943913786"],"abstract_inverted_index":{"PURPOSE:":[0],"Pertuzumab":[1,177,219],"represents":[2],"a":[3,73,111,198,239],"new":[4],"class":[5],"of":[6,20,34,76,102,170,195,258],"targeted":[7],"anticancer":[8],"agents,":[9],"human":[10],"epidermal":[11],"growth":[12],"factor":[13],"receptor":[14],"(HER)":[15],"dimerization":[16,260],"inhibitors.":[17],"The":[18,89],"aim":[19],"this":[21],"single-arm":[22],"phase":[23],"II":[24],"clinical":[25,263],"study":[26],"was":[27,93,118,178,182,204,220],"to":[28,191],"assess":[29],"the":[30,183],"efficacy":[31],"and":[32,96,127,223],"safety":[33],"single-agent":[35],"pertuzumab":[36,55,79,207,251],"in":[37,145,152,225,265],"castration-resistant":[38,60],"prostate":[39],"cancer":[40],"(CRPC)":[41],"patients":[42,61,133,231],"who":[43],"had":[44,62,134,160,172,232],"experienced":[45,63],"progression":[46,64],"after":[47,65],"prior":[48],"chemotherapy.":[49],"PATIENTS":[50],"AND":[51],"METHODS:":[52],"Patients":[53,71,121],"received":[54,72],"every":[56],"3":[57],"weeks.":[58,176],"All":[59],"at":[66,165],"least":[67,166],"one":[68,169],"taxane-based":[69],"regimen.":[70],"loading":[74],"dose":[75],"840":[77],"mg":[78,85],"(cycle":[80],"1)":[81],"followed":[82],"by":[83,141],"420":[84],"for":[86,110,164,174],"subsequent":[87],"cycles.":[88],"primary":[90],"end":[91],"point":[92],"overall":[94],"response":[95,138],"safety.":[97],"A":[98],"separate":[99],"retrospective":[100],"analysis":[101,194,244],"actual":[103],"survival":[104,108,196,203,248],"time":[105,109,249],"versus":[106],"predicted":[107],"patient":[112],"population":[113],"with":[114,206,210,213,250,253],"comparable":[115],"prognostic":[116,216],"features":[117],"performed.":[119],"RESULTS:":[120],"were":[122],"enrolled":[123],"(N":[124],"=":[125,130],"42)":[126],"treated":[128],"(n":[129],"41).":[131],"No":[132],"complete":[135],"or":[136,149],"partial":[137],"(as":[139],"defined":[140],"Response":[142],"Evaluation":[143],"Criteria":[144],"Solid":[146],"Tumors":[147],"Group":[148],"50%":[150],"decline":[151],"prostate-specific":[153],"antigen).":[154],"Of":[155],"30":[156],"efficacy-assessable":[157],"patients,":[158],"five":[159,171],"stable":[161],"disease":[162],"(SD)":[163],"23":[167,236],"weeks;":[168],"SD":[173,233],"36":[175],"well":[179,221],"tolerated;":[180],"diarrhea":[181],"most":[184],"common":[185],"adverse":[186],"effect":[187],"(61.0%,":[188],"grades":[189],"1":[190],"3).":[192],"Retrospective":[193,243],"using":[197],"validated":[199],"nomogram":[200],"suggested":[201,245],"that":[202],"prolonged":[205,246],"treatment,":[208],"compared":[209,252],"historic":[211],"controls":[212],"similar":[214],"baseline":[215],"features.":[217],"CONCLUSION:":[218],"tolerated":[222],"resulted":[224],"no":[226],"objective":[227],"responses,":[228],"but":[229],"several":[230],"more":[234],"than":[235],"weeks":[237],"from":[238],"heavily":[240],"pretreated":[241],"population.":[242],"median":[247],"historical":[254],"controls.":[255],"Thus,":[256],"inhibition":[257],"HER":[259],"may":[261],"have":[262],"utility":[264],"CRPC":[266],"patients.":[267]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":12}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}